Clinical translation of angiogenesis inhibitors
Top Cited Papers
- 1 October 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 2 (10), 727-739
- https://doi.org/10.1038/nrc905
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- The Hallmarks of CancerCell, 2000
- Thalidomide — A Revival StoryThe New England Journal of Medicine, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaThe New England Journal of Medicine, 1999
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470The New England Journal of Medicine, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aThe New England Journal of Medicine, 1989
- Successful Treatment of an Angiogenic DiseaseThe New England Journal of Medicine, 1989